A Whole New Market Is Giving This Cancer-Testing Stock A Boost
Shares of Exact Sciences – the company behind the at-home colon-cancer test Cologuard – got a boost recently when the FDA approved (earlier than expected)…
Shares of Exact Sciences – the company behind the at-home colon-cancer test Cologuard – got a boost recently when the FDA approved (earlier than expected)…